Emma Weatherley | FSHD Research & Cure FSHD Clinical Trial Passport Update | MDQ Seminar 27.5.25

Emma Weatherley, Managing Director of FSHD Global Research Foundation, presents the latest updates on clinical research and international advancements in facioscapulohumeral muscular dystrophy (FSHD), including the development of the Cure FSHD Clinical Trial Passport. This presentation was delivered as part of Muscular Dystrophy Queensland’s Neuromuscular Medical Seminar on 27 May 2025. In this session, Emma shares: An overview of FSHD and its global research landscape Progress toward potential therapies and clinical trials Details about the Cure FSHD Clinical Trial Passport initiative How people living with FSHD can engage in research opportunities For more information or to get involved in FSHD research, visit www.fshdglobal.org or contact MDQ at [email protected]. Learn more at www.mdqld.org.au